Incyte
$71.86
24H
Market Cap
Volume
Supply
Price Chart
About Incyte - INCY
Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics for oncology and other serious medical conditions. Their portfolio includes drug candidates at various stages of clinical development, and they have a track record of bringing innovative treatments to market.
What are Incyte's core values and mission statement?
Incyte Corporation's mission is focused on discovering, developing, and delivering novel medicines that meet serious unmet medical needs in oncology and other areas. Their core values emphasize a commitment to scientific excellence, innovative research, and the drive to provide meaningful differences in patients' lives.
Who founded Incyte and when?
Incyte Corporation was founded by Randy Scott and Roy Whitfield in April 1991.
Who leads Incyte?
Incyte Corporation is led by its CEO, Hervé Hoppenot.
Where is Incyte located, and what is its base country?
Incyte Corporation is headquartered in Wilmington, Delaware, United States. Its base country is the United States of America.
On which exchanges is Incyte traded?
Incyte Corporation is traded on the NASDAQ Stock Exchange under the ticker symbol INCY.
Historical data
Incyte (INCY) Price Live Data
The live price of Incyte (INCY) is $71.86, with a trading volume of 1,064,043 in the last 24 hours. Wrapstocks updates the INCY price in real-time. Incyte is down -5.35% in the last 24 hours. The company has a live market cap of $13,843,828,736.00 and a supply of 192,649,996 INCY stocks.
Incyte (INCY) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 6 hours and 3 minutes.
